Stem-cell science advanced each time someone learned to ask a cell what it could become. The last lesson was the quietest: the answer depends on where you ask. These are the names and the years.
At the Ontario Cancer Institute in Toronto, James Till and Ernest McCulloch show that single bone-marrow cells transplanted into irradiated mice form spleen colonies that both renew themselves and produce multiple blood lineages — the founding definition of a stem cell, established by what a cell becomes.
Till J.E., McCulloch E.A., Radiation Research 14, 213 (1961)
John Gurdon at Oxford replaces the nucleus of a frog egg with the nucleus of a differentiated intestinal cell — and the egg develops into a normal tadpole. Differentiation is not a one-way door: a mature cell's nucleus still holds the whole instructions. The Nobel committee will remember this in 2012.
James Thomson's team at the University of Wisconsin–Madison derives the first human embryonic stem-cell lines from blastocysts — human pluripotency becomes a material the laboratory can keep, expand and direct. The ethical debate it ignites shapes the next decade of policy.
Thomson J.A. et al., Science 282, 1145 (1998) — doi:10.1126/science.282.5391.1145
At Kyoto University, Kazutoshi Takahashi and Shinya Yamanaka screen candidate genes and find that just four factors — Oct3/4, Sox2, Klf4, c-Myc — return an ordinary mouse cell to pluripotency: the induced pluripotent stem cell. Human iPSCs follow in 2007. Any patient can now, in principle, supply their own stem cells.
Takahashi K., Yamanaka S., Cell 126, 663 (2006) — doi:10.1016/j.cell.2006.07.024
The Nobel Prize in Physiology or Medicine goes jointly to John Gurdon and Shinya Yamanaka "for the discovery that mature cells can be reprogrammed to become pluripotent" — joining the 1962 frog experiments to the iPSC revolution in a single arc.
Madeline Lancaster, working with Jürgen Knoblich in Vienna, grows cerebral organoids: embedded in a supportive matrix and given the right conditions, pluripotent stem cells self-organise into discrete, interdependent brain regions. The field's lesson lands — control the environment and the cells write the tissue themselves.
Lancaster M.A. et al., Nature 501, 373 (2013) — doi:10.1038/nature12517
The International Society for Stem Cell Research turns the field's ethics and rigour into living guidelines, updated as the science moves. In parallel, the organ-on-a-chip field — launched by the Wyss Institute's 2010 lung-on-a-chip — matures into commercial platforms and, from 2022, regulatory acceptance under the FDA Modernization Act 2.0.
ISSCR Guidelines · Huh/Ingber et al., Science 2010 · FDA Modernization Act 2.0
Till and McCulloch proved a stem cell by what it became; every assay since has graded cells the same way — destroy the culture, read the verdict. StemsChip, invented at Panacea Bio Chem by Bogdan Dicoias, is the stem-cell-focused organ-chip that turns the becoming itself into the measurement: expansion watched as a process, differentiation mapped as a landscape, peptides tested against living populations rather than snapshots. The purpose is public; the blueprint stays Panacea intellectual property until peer review.
In-house platform · design disclosure follows peer review